Human Molecular Genetics, 2000, Vol. 9, No. 6 987-992
© 2000 Oxford University Press
The proteolipid protein gene and myelin disorders in man and animal models
Applied Neurobiology Group, Glasgow University Veterinary School, Bearsden Road, Glasgow G61 1QH, UK and 1Clinical and Molecular Genetics Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
The two proteins, proteolipid protein and DM20, which are encoded by alternative transcripts from the proteolipid protein (PLP) gene, are major components of central nervous system myelin. In man, mutations of these proteins cause Pelizaeus–Merzbacher disease (PMD), an X-linked dysmyelinating neuropathy. The mutations found are very varied, ranging from deletions, loss-of-function and missense mutations to additional copies of the gene. This same range of known genetic defects has been observed in animal models with spontaneous and engineered Plp gene mutations. The relationship between genotype and phenotype is remarkably close in the animal models and the PMD cases, making them useful models for studying the mechanisms of PLP gene-related disease. As a result, it has become clear that the PLP gene plays a wider role in neural development in addition to its function as a structural component of myelin. It has also emerged that duplications of the PLP gene are the commonest mutation in PMD. Genetic disorders arising from a dosage effect may be more common than previously recognized. The study of the PLP gene in this rare disorder is, therefore, contributing both to our understanding of neural development and maintenance and to the mechanisms of human genetic disorders.
+ To whom correspondence should be addressed. Tel: +44 141 330 5700; Fax: +44 141 942 7215; Email: d.yool@vet.gla.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Roboti, E. Swanton, and S. High Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein J. Cell Sci., November 1, 2009; 122(21): 3942 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Wilkins and N Scolding Protecting axons in multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1013 - 1025. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Swanton, A. Holland, S. High, and P. Woodman Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum PNAS, March 22, 2005; 102(12): 4342 - 4347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Miller, M. A. Haxhiu, P. Georgiadis, T. I. Gudz, C. D. Kangas, and W. B. Macklin Proteolipid Protein Gene Mutation Induces Altered Ventilatory Response to Hypoxia in the Myelin-Deficient Rat J. Neurosci., March 15, 2003; 23(6): 2265 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Reid Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias J. Med. Genet., February 1, 2003; 40(2): 81 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. Edgar, T.J. Anderson, P.J. Dickinson, J.A. Barrie, M.C. McCulloch, K.-A. Nave, and I.R. Griffiths Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene J. Cell Biol., August 19, 2002; 158(4): 719 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. Garbern, D. A. Yool, G. J. Moore, I. B. Wilds, M. W. Faulk, M. Klugmann, K.-A. Nave, E. A. Sistermans, M. S. van der Knaap, T. D. Bird, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation Brain, May 1, 2002; 125(3): 551 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Wu, R. B. Reed, P. J. Grabowski, and K. Artzt Function of quaking in myelination: Regulation of alternative splicing PNAS, April 2, 2002; 99(7): 4233 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Wu, R. B. Reed, P. J. Grabowski, and K. Artzt Function of quaking in myelination: Regulation of alternative splicing PNAS, April 2, 2002; 99(7): 4233 - 4238. [Abstract] [Full Text] [PDF]
|
|